Characterization of Gastric Evoked Potentials

Running, not enrolling · Not applicable

Conditions studied: Healthy

In brief

This is an exploratory study that will determine and standardize how best to record gastric evoked potentials (GEPs) elicited by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS), by optimizing the TMS parameters and cortical sites necessary to evoke GEPs.

Key facts

Study ID

NCT05924009

Run by

University of Pittsburgh

People needed

155

Starts

2023-06-17

Expected to finish

2027-07-01

Last updated by the study team

2026-07-24

Who can join

Age: 21 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• psychosis or altered cognitive status
• history of head injury, metal in the skull, stroke, or a history of seizures, loss of consciousness or syncope
• implantable devices, such as a pacemaker or nerve stimulator
• current use of antiepileptic medications or current use of the following medications or substances which are known to lower the seizure threshold: Clozapine (Clozaril), Chlorpromazine (Thorazine), amphetamines or methamphetamine, Ecstasy, Ketamine, Angel Dust/PCP, cocaine, or 3 or more alcoholic drinks per day
• pregnancy
• BMI > 30
• history of bariatric surgery such as sleeve gastrectomy or Roux-en-Y gastric bypass
• diabetes
• suffering from a neurodegenerative disorder.

Where it is running

• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.